Published in Int J Chron Obstruct Pulmon Dis on January 01, 2007
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2007) 5.51
Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial. COPD (2004) 1.46
Roger s. Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance. Proc Am Thorac Soc (2006) 1.23
Role of tiotropium in the treatment of COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.99
Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis (2007) 0.95
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc Natl Acad Sci U S A (2011) 2.38
Predictors of objective cough frequency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.64
Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial. Int J Chron Obstruct Pulmon Dis (2012) 1.52
Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies. Int J Chron Obstruct Pulmon Dis (2010) 1.51
Increased airway T regulatory cells in asthmatic subjects. Chest (2010) 1.50
Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study. Eur Respir J (2012) 1.50
A comparison of lung function methods for assessing dose-response effects of salbutamol. Br J Clin Pharmacol (2004) 1.45
Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest (2002) 1.27
MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 1.27
CD4-regulatory cells in COPD patients. Chest (2007) 1.27
alpha,beta-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am J Physiol Lung Cell Mol Physiol (2009) 1.24
Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes. Respir Med (2008) 1.19
Safety of indacaterol in the treatment of patients with COPD. Int J Chron Obstruct Pulmon Dis (2011) 1.19
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med (2014) 1.11
Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One (2011) 1.11
Fly larvae for wound management: a maggot makeover. N S W Public Health Bull (2005) 1.08
Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med (2009) 1.06
The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD. Br J Clin Pharmacol (2008) 1.06
Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor. J Endocrinol (2008) 1.05
The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD. Eur Respir J (2013) 1.04
Impact factor and its role in academic promotion. Int J Chron Obstruct Pulmon Dis (2009) 1.04
Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs. Eur Respir J (2012) 1.02
Cigarette smoke and its component acrolein augment IL-8/CXCL8 mRNA stability via p38 MAPK/MK2 signaling in human pulmonary cells. Am J Physiol Lung Cell Mol Physiol (2012) 0.98
The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulmon Dis (2009) 0.98
The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: differing perceptions from a survey of adult and paediatric gastroenterologists. J Crohns Colitis (2012) 0.98
T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease. Respir Res (2012) 0.97
COPD phenotype description using principal components analysis. Respir Res (2009) 0.97
Setting the standard for routine asthma consultations: a discussion of the aims, process and outcomes of reviewing people with asthma in primary care. Prim Care Respir J (2010) 0.97
Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax (2011) 0.97
Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine (2008) 0.95
Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res (2011) 0.95
Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 0.94
Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2. J Pharmacol Exp Ther (2013) 0.93
Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst (2010) 0.93
Beauty is in the 'we' of the beholder: greater agreement on facial attractiveness among close relations. Perception (2007) 0.92
A comparison of exhaled nitric oxide measurements performed using three different analysers. Respir Med (2006) 0.92
Aspects of facial contrast decrease with age and are cues for age perception. PLoS One (2013) 0.91
LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2. Int Immunopharmacol (2012) 0.91
Loss of glucocorticoid receptor expression by DNA methylation prevents glucocorticoid induced apoptosis in human small cell lung cancer cells. PLoS One (2011) 0.89
Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects. Br J Clin Pharmacol (2012) 0.88
Crossing the 'uncanny valley': adaptation to cartoon faces can influence perception of human faces. Perception (2010) 0.88
The effects of dexamethasone on cigarette smoke induced gene expression changes in COPD macrophages. Int Immunopharmacol (2009) 0.87
Reduced glucocorticoid receptor expression and function in airway neutrophils. Int Immunopharmacol (2011) 0.87
MR Quantitative Equilibrium Signal Mapping: A Reliable Alternative to CT in the Assessment of Emphysema in Patients with Chronic Obstructive Pulmonary Disease. Radiology (2015) 0.86
Evaluation of glucocorticoid receptor function in COPD lung macrophages using beclomethasone-17-monopropionate. PLoS One (2013) 0.86
Down regulation of T cell receptor expression in COPD pulmonary CD8 cells. PLoS One (2013) 0.84
Non-invasive biomarkers and pulmonary function in smokers. Int J Chron Obstruct Pulmon Dis (2008) 0.84
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum. Respir Res (2014) 0.83
Novel anti-inflammatory agents in COPD: targeting lung and systemic inflammation. Curr Drug Targets (2013) 0.83
The role of the liver X receptor in chronic obstructive pulmonary disease. Respir Res (2013) 0.83
Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease. Br J Clin Pharmacol (2015) 0.82
The EvA study: aims and strategy. Eur Respir J (2012) 0.81
CRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in CD8 cells from COPD patients. Clin Sci (Lond) (2014) 0.81
Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma. Respir Res (2007) 0.81
Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study. Respir Res (2012) 0.81
Reduced exhaled breath condensate pH in asthmatic smokers using inhaled corticosteroids. Respirology (2009) 0.80
Bed bugs - What the GP needs to know. Aust Fam Physician (2009) 0.80
Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor. Br J Clin Pharmacol (2015) 0.80
A comparison of the clinical and induced sputum characteristics of early- and late-onset asthma. Lung (2012) 0.78
P38 inhibition in COPD; cautious optimism. Thorax (2013) 0.78
Diesel exhaust particle exposure in vitro alters monocyte differentiation and function. PLoS One (2012) 0.78
The effects of smoking on the lipopolysaccharide response and glucocorticoid sensitivity of alveolar macrophages of patients with asthma. Chest (2009) 0.77
The reproducibility of bolus allergen challenges; power calculations for clinical trials. Eur J Clin Pharmacol (2012) 0.77
High- and low-dose allergen challenges in asthmatic patients using inhaled corticosteroids. Br J Clin Pharmacol (2015) 0.77
Computational models of facial attractiveness judgments. Perception (2008) 0.77
Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal. Allergy Asthma Proc (2012) 0.77
A perceptually based comparison of image similarity metrics. Perception (2011) 0.77
A cluster of locally-acquired Ross River virus infection in outer western Sydney. N S W Public Health Bull (2000) 0.76
The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma. BMC Pulm Med (2014) 0.76
Tiotropium; more knowledge leads to more questions. Int J Chron Obstruct Pulmon Dis (2008) 0.76
The benefits of combined treatment with corticosteroids and long-acting beta agonists. Int J Chron Obstruct Pulmon Dis (2006) 0.76
The effects of corticosteroids on cytokine production from asthma lung lymphocytes. Int Immunopharmacol (2014) 0.76
Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease. Br J Clin Pharmacol (2015) 0.76
Airway inflammation in asthma: multiple roles for thymic stromal lymphopoietin. Chest (2012) 0.75
Seretide withdrawal increases airway inflammation in moderate COPD patients. Eur J Clin Pharmacol (2009) 0.75
Duration of luteal support (DOLS) with progesterone pessaries to improve the success rates in assisted conception: study protocol for a randomized controlled trial. Trials (2012) 0.75
Cyclic hydrostatic pressure and cotton particles stimulate synthesis by human lung macrophages of cytokines in vitro. Respir Res (2009) 0.75
Role of Faecalibacterium prausnitzii in Crohn's Disease: friend, foe, or does not really matter? Inflamm Bowel Dis (2014) 0.75
Facial contrast is a universal cue for perceiving age. J Vis (2015) 0.75
Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. Expert Rev Respir Med (2012) 0.75
Facial contrast is a cue for health perception. J Vis (2015) 0.75
Malaria. N S W Public Health Bull (2006) 0.75
Novel anti-inflammatory treatments for asthma. Expert Rev Respir Med (2008) 0.75
Management of acute asthma in the UK. Emerg Med J (2013) 0.75
Critical assessment of the value of sputum neutrophils. COPD (2013) 0.75
The big picture and the little picture. Int J Chron Obstruct Pulmon Dis (2006) 0.75
Children must be protected from the tobacco industry's marketing tactics. BMJ (2013) 0.75
Prevalence of airflow obstruction in patients attending a rapid access chest pain clinic. Respir Med (2008) 0.75
Deceptive debris. Radiol Technol (2003) 0.75